RAFFERTY ASSET MANAGEMENT, LLC – CRISPR Therapeutics AG Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$6.76M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +72.76% | 43.56K shares | 3.12M | $65.35 | 103.44K |
| Q2 2022 | share | Increase | +131.53% | 34.01K shares | 2.01M | $60.77 | 59.87K |
| Q1 2022 | share | Decrease | -11.63% | -3.40K shares | -595K | $62.77 | 25.86K |
| Q4 2021 | share | Increase | +2.55% | 727 shares | -976K | $78.85 | 29.26K |
| Q3 2021 | share | Decrease | -9.52% | -3.00K shares | -1.91M | $111.93 | 28.53K |
| Q2 2021 | share | Increase | 0.00% | 31.53K shares | 5.10M | $161.89 | 31.53K |